Reliability of antibody tests for COVID-19 diagnosis

被引:0
|
作者
Coplu, Nilay [1 ]
Kilinc, Cetin [2 ]
Gozalan, Aysegul [3 ]
Calisir, Busra [2 ]
Sonmez, Cemile [4 ,5 ]
Gul, Mustafa Muhammet [6 ]
Aygun Ahlatcioglu, Zeynep
机构
[1] Ankara City Hosp, Med Microbiol, Ankara, Turkiye
[2] Kastamonu Training & Res Hosp, Med Microbiol, Kastamonu, Turkiye
[3] Alanya Alaaddin Keykubat Univ, Med Microbiol, Antalya, Turkiye
[4] Minist Hlth, Microbiol Reference Labs, Ankara, Turkiye
[5] Minist Hlth, Biol Prod Dept, Sexually Transmitted Dis Reference Lab, Publ Hlth Gen Directorate, Ankara, Turkiye
[6] Kastamonu Training & Res Horpital, Infect Dis Clin, Kastamonu, Turkiye
来源
MARMARA MEDICAL JOURNAL | 2023年 / 36卷 / 01期
关键词
COVID-19; Antibody; Validity; Chemiluminescent; Electrochemiluminescence; ELISA; PERFORMANCE;
D O I
10.5472/marumj.1245068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The reverse transcription-polymerase chain reaction test (RT-PCR) is the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), and antibody tests are useful as supplemental tools for diagnosis, for measuring the population's immunity levels, and for checking infection in asymptomatic contacts. This study aimed to evaluate the reliability of five commercial antibody detection test kits. Materials and Methods: The reliability of the Colloidal Gold COVID-19 IgG/IgM Rapid Test Kit, Antibody Rapid Test Hotgen, Beijing Hotgen Biotech Co., Ltd., China), Abbott Chemiluminescent Microparticle Immunoassay (Illinois, USA), Roche Electrochemiluminescence Immunoassay (Roche Diagnostics, Switzerland), Siemens Chemiluminescence (Munich, Germany), and Euroimmun ELISA (Lubeck, Germany) for COVID-19 diagnosis was studied. The antibody-negative group included 50 sera from 2018, and the antibody-positive group included 98 patients with positive RT-PCR results from whom blood samples had been collected 3-9 weeks after hospital discharge. Statistical analysis was performed using SPSS version 23.0 (IBM Corporation, Armonk, NY, USA). The antibody tests' validity and intra-assay reproducibility were examined, and the Cohen's kappa coefficients were obtained. The disease prevalence was pegged at 10%. Results: The antibody tests' sensitivity (69.12-72.46%) and positive predictive values (42.44-100.0%) were low, and their specificity (89.58-100%) and negative predictive values (96.31-97.03%) were high. Their accuracy rates varied from 87.54% to 97.25%, and their intra-assay coefficients of variation varied from 1% to 10%. Conclusion: The agreement between the results of the antibody detection test kits was higher when the kits were classified according to the targeted antigens. The time of blood sample collection, targeted antigens, and antibody types affected the results. Serological tests were found to be useful, and the commercial kits were found to be largely reliable, although, some parameters need to be improved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 50 条
  • [21] Principles of commercially available Tests for the Diagnosis of COVID-19
    Siekmeier, Rudiger
    Hannig, Jurgen
    Grammer, Tanja
    Marz, Winfried
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 5) : 185 - 185
  • [22] FDA adjusts course on validating COVID-19 antibody tests
    Kemsley, Jyllian
    CHEMICAL & ENGINEERING NEWS, 2020, 98 (18) : 16 - 16
  • [23] Antibody tests for COVID-19: What the results tell us
    Horvath, Karl
    Semlitsch, Thomas
    Jeitler, Klaus
    Krause, Robert
    Siebenhofer, Andrea
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2020, 153 : 54 - 59
  • [24] Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?
    Weinstein, Milton C.
    Freedberg, Kenneth A.
    Hyle, Emily P.
    Paltiel, A. David
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (06): : e37
  • [25] COVID-19 antibody tests raise as many questions as they answer
    Satyanarayana, Megha
    CHEMICAL & ENGINEERING NEWS, 2020, 98 (22) : 29 - 33
  • [26] Antibody detection assays for COVID-19 diagnosis: an early overview
    Ejazi, Sarfaraz Ahmad
    Ghosh, Sneha
    Ali, Nahid
    IMMUNOLOGY AND CELL BIOLOGY, 2021, 99 (01): : 21 - 33
  • [27] Antibody tests for COVID-19: drawing attention to the importance of analytical specificity
    Diamandis, Phedias
    Prassas, Ioannis
    Diamandis, Eleftherios P.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) : 1144 - 1145
  • [28] The case for lowered positivity threshold for COVID-19 antibody screening tests
    Taubel, Jorg
    Cole, Samuel
    Camilleri, Dorothee
    Spencer, Christopher
    Freier, Anne
    Lorch, Ulrike
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1618 - 1619
  • [29] Covid-19: Timing is critical for antibody tests, finds Cochrane review
    Wise, Jacqui
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369 : m2584
  • [30] Evaluation of COVID-19 antibody response with using three different tests
    Appak, Ozgur
    Gulmez, Abdurrahman
    Guzel, Irmak
    Gezer, Naciye Sinem
    Doruk, Ozlem Gursoy
    Ergor, Osman Alparslan
    Esen, Nuran
    Sayiner, Ayca Arzu
    IRANIAN JOURNAL OF MICROBIOLOGY, 2021, 13 (05) : 565 - 573